Results 211 to 220 of about 70,621 (279)

Additional file 2: of Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1

, 2017
Masakazu Toi, Zhimin Shao, Sara Hurvitz, Ling-Ming Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Jifeng Feng, Binghe Xu, Xiaojia Wang, Keun Lee, Ting Ying Ng, Antonia Ridolfi, Florence Noël-Baron, François Ringeisen, Zefei Jiang   +15 more
openalex   +1 more source

Treatment patterns, health care resource utilization and costs, and clinical outcomes among older adult patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma. [PDF]

J Manag Care Spec Pharm
Wang L, Wang A, Valderrama A, Wang T, Mattera M, Zhou ZY, Sharan KP, Pintova S.   +7 more
europepmc   +1 more source

Case Report: Long-term control of brain metastases with over 100 cycles of T-DM1 in HER2-positive metastatic breast cancer. [PDF]

Front Oncol
Ko H, Choi SY, Kim D, Lee J.
europepmc   +1 more source

Maintenance therapy in hormone receptor-positive and human epidermal growth factor receptor 2-positive metastatic breast cancer: a real-world multicenter retrospective study. [PDF]

Front Oncol
Bao S, Chen J, Yin Y.
europepmc   +1 more source

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Randomized, Phase II Study. [PDF]

MedComm (2020)
Huang J, Wang H, Tong Y, Hong J, Zhu Y, Ren W, Yu J, Shi H, Gao W, Zhu S, Wu J, Huang O, Li J, He J, Chen W, Li Y, Shen K, Chen X.   +17 more
europepmc   +1 more source

Trojan horses at leptomeningeal cellular gates: Antibody-drug conjugates deliver cytotoxic payloads. [PDF]

Med
Nikanjam M, Kurzrock R.
europepmc   +1 more source

In vivo Auto-tuning of Antibody-Drug Conjugate Delivery to Maximize Efficacy using High-Avidity, Low-Affinity Antibodies. [PDF]

Mol Cancer Ther
Kopp A, Dong S, Kwon H, Wang T, Desai AA, Philippart A, Koo DJ, Linderman JJ, Tessier PM, Thurber GM.   +9 more
europepmc   +1 more source

Real-World Evaluation of a Trastuzumab Emtansine Biosimilar (Ujvira®) in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer. [PDF]

Cureus
Chandrakanth MV, Agarwala V, Manna R, Sharma A, Roy M, Dasgupta A, Mandal K, Sen N, Sardar PK, Sadhya A, Basu M, Kumar S, Nayak H, Thummar V, Mehta P.   +14 more
europepmc   +1 more source

Evidence-Based Consensus on the Diagnosis and Treatment of Advanced HER2-Positive and HER2-Low Breast Cancer in Colombia. [PDF]

J Clin Med
Lema M, Sua LF, Hernández Blanquisett AJ, Mantilla W, Pierre ME, Carranza H, Zuluaga Peña JR, Gutiérrez Raba AV, Franco SX.   +8 more
europepmc   +1 more source

The ROOT-CTRCD study: exploring the relationship of oral health to cancer therapy-related cardiac dysfunction in HER2-positive breast cancer patients. [PDF]

Cardiooncology
Basuoni A, Al-Baimani K, AlKindi F, Dawelbeit W, AlHarrasi R, Al-Sharqi H, AlKindi N, Kamel AHM.   +7 more
europepmc   +1 more source